Characterizing variation in use of norepinephrine for patients in septic shock and estimating potential lives saved if norepinephrine were universally used as the first-line agent

描述感染性休克患者使用去甲肾上腺素的变化，并估计如果普遍使用去甲肾上腺素作为一线药物，可能挽救的生命

• 批准号: 429095
• 负责人: Teja Bijan J
• 金额: $ 1.27万
• 依托单位: University of Toronto
• 依托单位国家: 加拿大
• 项目类别: Studentship Programs
• 财政年份: 2019
• 资助国家: 加拿大
• 起止时间: 2019-12-01 至 2020-12-01
• 项目状态: 已结题
• 来源: https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=429095&lang=en
• 关键词: Implementation Science; Mixed Effects Models; Monte Carlo Simulation; Norepinephrine; Quality Improvement; Septic Shock

"Septic shock is overwhelming infection with low blood pressure and is associated with a very high likelihood of death in the hospital (30-50%). These patients receive fluids and antibiotics. As well, they receive medications called vasopressors (such as

“感染性休克是一种压倒性的低血压感染，在医院死亡的可能性很高(30%-50%)。这些患者接受液体和抗生素治疗。此外，他们还接受称为血管加压药的药物(如